A Republican congressman who’s voted against modest measures to loosen barriers on psychedelic research seems to be coming around on the issue following discussions with advocates—including military veterans who have utilized the substances therapeutically—and now says the treatment “sounds amazing.”
Psychedelics
Is Access To Psychedelic Medicine The Largest Human Rights Issue Today?
The Mental Health Crisis is now a mental health pandemic. Is access to psychedelic medicine the world's largest human rights issue?
atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions
ATAI's newest research partner, Revixia Life Sciences, is seeking to treat depression and substance abuse with Salvinorin A, a lesser-known psychedelic used by indigenous peoples.
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
Compass Pathways reports a Q2 loss of $17.5 million and announces raising $154.8 million in a new financing in May.
Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury
Wesana Health announces the commencement of pre-clinical psychedelics research for Traumatic Brain Injury.
Psychedelic Medicine vs. Conventional Mental Health Therapies: Cures vs. Crutches
Two billion people have treatable mental health disorders. Where existing therapies are merely inadequate crutches, psychedelic drugs can produce cures.
Do you know the mushroom man?
Many places across the state recorded the rainiest July on record—that was great news for Kevyn Fowler.
Which Psychedelic Drug Has The Most Commercial Potential?
Psychedelic Stock Watch compares and contrasts the drug development opportunities with psychedelic drugs (and psychedelic drug stocks).
MINDCURE Appoints Jerry White, Award-Winning Humanitarian Activist Who Shares in the 1997 Nobel Peace Prize, as Company Advisor
MINDCURE announces that renowned human rights activist, Jerry White, has joined the company as an advisor. Winner of the Nobel Peace Prize, White will help MINDCURE revolutionize mental health.
Brain self-regulation training might reduce the neurological correlates of psychopathy in violent criminals
Psychopathy is a disorder characterized by lack of empathy and remorse, antisocial behavior, increased tendencies towards aggression and anger, and blunted anticipatory fear.
Psychedelics Decriminalization Advancing In Three More Cities, Spanning From Coast To Coast
From Massachusetts to California, advocates are actively making new strides to reform local laws governing psychedelics like psilocybin and ayahuasca—building on a national movement that has already seen numerous cities decriminalize entheogenic substances.
DEA Says Cancer Patients’ Request For Medical Psilocybin Could Fuel Illegal Drug Market
The U.S. Drug Enforcement Administration is asking a federal appeals court to throw out a lawsuit aimed at clearing a path to the therapeutic use of psilocybin, the main psychoactive compound in psychedelic mushrooms—arguing that allowing limited medical access could boost the illegal drug trade.
California Lawmakers Approve Bill To Legalize Psychedelics Possession In Committee
A California Assembly committee on Tuesday approved a Senate-passed bill to legalize possession of psychedelics, clearing its first major hurdle in the chamber.
Ayahuasca use associated with greatly improved anxiety and depression symptoms in large international study
Despite their illegality and a tendency among the media and politicians to demonize their use, psychedelics have been shown to have transformative effects on individuals suffering from mental health problems, including depression and anxiety.
Oregon State Board Says Psilocybin Is Effective At Treating Certain Mental Health Condition
An Oregon review panel established under the state’s voter-approved therapeutic psilocybin legalization initiative has released a report stating that the psychedelic holds significant medical value for a number of mental health conditions.